The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).
 
Sharon M. Castellino
No Relationships to Disclose
 
Qinglin Pei
No Relationships to Disclose
 
Susan K. Parsons
Consulting or Advisory Role - Seagen
 
David C. Hodgson
No Relationships to Disclose
 
Kathleen McCarten
No Relationships to Disclose
 
Angela Punnett
No Relationships to Disclose
 
Terzah M. Horton
No Relationships to Disclose
 
Hema Kishore Dave
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Steve Y. Cho
Consulting or Advisory Role - Blue Earth Diagnostics; Bristol-Myers Squibb; Haymarket Medical Education; Progenics; Radmetrix
Research Funding - Advanced Accelerator Applications (Inst); Progenics (Inst)
Other Relationship - Radmetrix
(OPTIONAL) Uncompensated Relationships - Focus-X Therapeutics
 
Yue Wu
No Relationships to Disclose
 
Tara O. Henderson
Other Relationship - Seagen
(OPTIONAL) Uncompensated Relationships - National Academies of Medicine, Engineering and Sciences Committee on Disability and Childhood Cancer
 
Bradford Hoppe
Consulting or Advisory Role - Merck (Inst)
 
Frank G. Keller
No Relationships to Disclose
 
Kara Kelly
No Relationships to Disclose